DNA(RNA) Synthesis

DNA(RNA) Synthesis

RNA synthesis, which is also called DNA transcription, is a highly selective process.Beyond RNA synthesis, RNA polymerase II transcription plays a more active role in the maturation, monitoring, and export of mRNA to the cytoplasm.

In order to fully repair the DNA after a single-strand break, DNA ligase constructs the final phosphodiester bond using the complementary strand of the double helix as a template.Substrates with RNA strands or mismatched base pairs near the ends of the nicked DNA are discriminated against by DNA ligases. Bleomycin (BLM) is a S-independent radiomimetic agent that damages DNA by creating free radicals that attack the C-4′ position in the deoxyribose backbone. This causes the ribose ring to open and strand breaks to occur.

M-MuLV Reverse Transcriptase (RNase H) and random hexamer primers are used to create first strand cDNA. The next step involves the use of DNA Polymerase I and RNase H to create second strand cDNA. Exonuclease/polymerase activity transforms the remaining overhangs into blunt ends. DNA fragments' 3′ ends are adenylated before being ligated with a NEBNext Adaptor with a hairpin loop structure to get the samples ready for hybridization. The two pathways that BET bromodomain inhibition most commonly affects are cell cycle and DNA replication. The translation of mRNA into proteins is inhibited by cycloheximide.

DNA(RNA) Synthesis related products

Structure Cat No. Product Name CAS No. Product Description
V52362 BAY-364 (BAY-299N) 2097610-30-3 BAY-364 (BAY-299N) is an inhibitor of the second bromodomain in TAF1.
V51479 BC-LI-0186 695207-56-8 BC-LI-0186 is a novel Leucyl-tRNA synthetase (LRS; LeuRS) inhibitor and Ras-related GTP-binding protein D (RagD) interaction (IC50=46.11 nM).
V2269 BCH001 384859-58-9 BCH001 is a quinoline analogue and a selective PAPD5 inhibitor.
V1466 Bendamustine HCl (SDX-105) 3543-75-7 Bendamustine HCl (formerly also called SDX-105;EP-3101; Cytostasane; DD6304600; Treanda), the hydrochloride salt of bendamustine which is a bifunctional mechlorethamine derivative, is a potent DNA-alkylating/ cross-linking / damaging agent (IC50 = 50 μM in cell-free assay) approved for cancer treatment.
V55132 Bersiporocin (DWN12088) 2241808-52-4 Bersiporocin is a novel and potent prolyl-tRNA synthetase inhibitor.
V1437 Blasticidin S HCl 3513-03-9 Blasticidin S HCl, the hydrochloride salt of Blasticidin S, is a naturally occurring nucleoside antibiotic extracted from Stretomyces girseochromogenes.
V1424 Bleomycin Sulfate 9041-93-4 Bleomycin Sulfate (also known as NSC125066; NSC-125066; BLEO-cell; Bleolem; Blenoxane; Blanoxan), the sulfate salt of Bleomycin, is a glycopeptide antibiotic and an anticancer agent approved for treating a variety of cancers including Hodgkin's lymphoma, non-Hodgkin's lymphoma, ovarian cancer, testicular cancer, and cervical cancer.
V78484 BLM-IN-2 BLM-IN-2 is an inhibitor (blocker/antagonist) of Bloom's syndrome protein (BLM) with IC50 of 0.8 μM.
V1435 BMH-21 896705-16-1 BMH-21 (BMH 21; BMH21) is a novel and potent DNA intercalator with potential antineoplastic activity.
V2335 Bractoppin 2290527-07-8 Bractoppin is a potent and selective inhibitor of phosphopeptide recognition by the BRCA1 tBRCT domain, which selectively interrupts BRCA1 tBRCT-dependent signals evoked by DNA damage.
V3852 Branaplam (LMI070) 1562338-42-4 LMI-070 (Branaplam; NVS-SM1) is a potent, orally bioactive, small-molecule enhancer of SMN2 (survival of motor neuron-2) splicing that elevates full-length SMN protein and extends survival in a severe SMA mouse model.
V3853 Branaplam (LMI070) HCl 1562338-39-9 Branaplam HCl (LMI-070 HCl; NVS-SM1) is a potent, orally bioactive, small-molecule enhancer of SMN2 (survival of motor neuron-2) splicing that elevates full-length SMN protein and extends survival in a severe SMA mouse model.
V46895 Branaplam diHCl 1562338-39-9 Branaplam diHCl (LMI-070 dihydrochloride; NVS-SM1) is a potent, orally bioactive, small-molecule enhancer of SMN2 (survival of motor neuron-2) splicing that elevates full-length SMN protein and extends survival in a severe SMA mouse model.
V34685 Bromochloroacetonitrile (bromochloroacetonitrile) 83463-62-1 Bromochloroacetonitrile is a byproduct of water treated with chlorine that contains organic matter.
V1431 Bromodeoxyuridine (BrdU) 59-14-3 Bromodeoxyuridine (BrdU; Broxuridine; 5-Bromo-2-deoxyuridine; BUdR) is a nucleoside analog with potential anticancer activity.
V2277 Brr2 inhibitor C9 2104030-82-0 Brr2 inhibitor C9 (no formal name but also known as Brr2 Inhibitor 9 ) is an allosteric inhibitor of the spliceosomal RNA helicase Brr2.
V54316 BVDU 5′-Triphosphate ((E)-5-(2-Bromovinyl)-dUTP; BVdUTP) 77222-61-8 BVDU 5′-Triphosphate is a 5′-Triphosphate tagged antiviral agent that targets the viral DNA polymerase.
V52309 BVDV-IN-1 345651-04-9 BVDV-IN-1 is a bovine viral diarrhea virus (BVDV) non-nucleoside inhibitor (NNI) with an EC50 value of 1.8 μM.
V55194 Bz-rC Phosphoramidite 118380-84-0 Bz-rC Phosphoramidite is a phosphoramidite monomer that may be utilized in the preparation of oligonucleotides.
V1454 Capecitabine (Xeloda) 154361-50-9 Capecitabine (formerly RO 09-1978; RO-09-1978; RO09-1978; CAPE; Trade name: Xeloda) is an anticancer chemotherapeutic medication approved for treating breast cancer, gastric cancer and colorectal cancer.
Contact Us Back to top